Fetal ERAP2 Variation and Preeclampsia Risk in African Americans
Author Information
Author(s): Lori D Hill, DaShaunda D Hilliard, Timothy P York, Sindhu Srinivas, Juan P Kusanovic, Ricardo Gomez, Michal A Elovitz, Roberto Romero, Jerome F Strauss III
Primary Institution: Virginia Commonwealth University School of Medicine
Hypothesis
Does fetal ERAP2 variation increase the risk of preeclampsia in African Americans?
Conclusion
Fetal ERAP2 variation is associated with an increased risk of preeclampsia in African Americans.
Supporting Evidence
- The fetal minor allele (G) of rs2549782 was associated with increased risk for preeclampsia in the African American population.
- No association was found between rs17408150 and risk for preeclampsia in the Chilean population.
- Previous studies have linked ERAP2 to preeclampsia in other populations.
Takeaway
This study found that a specific gene variation in babies can make them more likely to develop a serious pregnancy condition called preeclampsia, especially in African American mothers.
Methodology
A case-control study design was used to analyze the association between two SNPs in the ERAP2 gene and preeclampsia status in Chilean and African American populations.
Limitations
The study had limited statistical power to detect very small effects and only tested two SNPs in the ERAP2 gene.
Participant Demographics
Chilean and African American populations, including maternal-fetal dyads and unpaired samples.
Statistical Information
P-Value
0.009
Confidence Interval
1.099, 2.128
Statistical Significance
p=0.009
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website